Comparative Pharmacology
Head-to-head clinical analysis: ACHROMYCIN V versus DYNA HEX 2.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACHROMYCIN V versus DYNA HEX 2.
ACHROMYCIN V vs DYNA-HEX 2
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Bacteriostatic; binds reversibly to 30S ribosomal subunit, inhibits protein synthesis by blocking aminoacyl-tRNA binding to mRNA-ribosome complex.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged bacterial cell walls, causing leakage of intracellular contents and cell death. It has broad-spectrum activity against gram-positive and gram-negative bacteria, fungi, and some viruses.
250-500 mg orally every 6 hours
1-2 mg IV/IM every 4-6 hours as needed for anxiety, up to 10 mg/day.
None Documented
None Documented
Terminal elimination half-life is 6-12 hours in patients with normal renal function; prolonged in renal impairment (up to 48-72 hours in anuria).
2-4 hours; prolonged in renal impairment (up to 10-12 hours in anuria).
Renal (60% unchanged in urine via glomerular filtration), biliary/fecal (40% as active drug and metabolites, with a portion undergoing enterohepatic recirculation).
Primarily renal (70-80% unchanged) with minor biliary excretion (<5%) and fecal elimination (<5%).
Category C
Category C
Tetracycline Antibiotic
Tetracycline Antibiotic